Company Filing History:
Years Active: 2010-2012
Title: Michelle Bich Tran-Dubé: Innovator in Pharmaceutical Development
Introduction
Michelle Bich Tran-Dubé is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target abnormal cell growth. With a total of two patents to her name, her work is paving the way for advancements in cancer treatment.
Latest Patents
Tran-Dubé's latest patents include innovative compounds that have the potential to revolutionize cancer therapy. One of her notable inventions is related to polymorphs of a c-MET/HGFR inhibitor. This invention focuses on polymorphs of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, which are useful in treating abnormal cell growth, such as cancer, in mammals. Additionally, she has developed triazolopyrazine derivatives, which are compounds that can be used in pharmaceutical compositions to treat hyperproliferative disorders in mammals.
Career Highlights
Michelle Bich Tran-Dubé is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role involves extensive research and development in the field of drug formulation and therapeutic applications. Her innovative approach and dedication to her work have earned her recognition in the industry.
Collaborations
Throughout her career, Tran-Dubé has collaborated with esteemed colleagues, including Jingrong Jean Cui and Hengmiao Cheng. These collaborations have fostered a productive environment for innovation and have contributed to the success of her projects.
Conclusion
Michelle Bich Tran-Dubé is a trailblazer in the pharmaceutical industry, with her inventions holding promise for the treatment of serious health conditions. Her contributions are vital to the ongoing fight against cancer and other hyperproliferative disorders.